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apaxin 93 subjects (14%). Moderate or severe LV dysfunction was present
in 98 patients (15%) and was more frequent in diffuse impairment (66%)
than in segmental impairment (42%), p = 0.004. Prevalence of impairment
and moderate or severe LV dysfunction increased progressively with age.
They peakad at the age group between 60 and 70 yeara in which they were
44% and 24%, respectively. These findings reflect the chronic and slowly
progressive evolution of this disease, as all these patients were probably
infected below age 20. Chronic Chagaa’ heart disease, in contrast with other
myocarditis, is associated with a segmental pattern of impairment that may
simulate ischemic cardiopathy.
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n7653 A Clinical and Histologic Comparison of IdiopathicGiant Call Myocarditia and Cardiac Sarcoidoala
L.T. Cooper, G.J. Berry, L. Olson, R. Shabetai. The Urrivemifyof CaVifomia
at SanDiego,SerrDiego,CA,USA,MayoClinic,RocheatetMN,USA
Idiopathic giant cell myooarditis (GCM) and oardiacaarcoidosis (CS) are rare
cauaea of heart failure both characterized by giant calls in the myocardium.
We seek to compare for the firat time the clinical presentation and course of
GCM and CS using a multicenter database. Methods:We utilized the Mul-
ticenter Giant Cell Myooarditis Study Group database to identify 45 oases
of idiopathic giant cell myocarditis and 14 cases of cardiac sarooidosis con-
firmed by a single cardiac pathologist. The diagnostic criteria for CS were
wall formed granuloma with multinucleatad giant cells (MGC) and for GCM
were widespread or serpiginous myooyte necrosis with MGC in the absence
of well-formed granuloma. Ofhercauses of giant cell reaction were excluded.
Results:The average age at time of symptom onset was 42.9 yrs (range
16+9 yra) for GCM and 45.6 yrs (range 30-80 yrs) for CS. The percentage
of males was 49Y0and 50Y0for GCM and CS, respectively.The respective
incidence of the following symptoms in GCM and CS patients was: cxm-
gestive heart failure 100% in both groups, ventricular tachycardia or cardiac
arrest: 52% and 21’7., and heart block: 13% and 36%. Sutvival from symp-
tom onset to death, transplantation, or end of follow-up was 13.9 months for
GCM and 44.0 months for CS (p c 0.001). 87Y0of GCM patienta and 93%
of CS patienta eventuallydied or required heart transplantation by end of
follow-up.
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Cone/uaions:Mortality is high amongst patients with CS and GMC; how-
ever, survival of GCM patients is significantly shorterthan that of CS patienta.
4:45
765-4 Cardiac Autoantibodias In Idiopathic Dilatad
Cardiomyopathy Ara Spscific Markers Aaaociated
With Early Disease
J.H. Goldman, M.K. Baig, A. Soltys, A.L.P. Caforio, W. McKenna. St.
George’s HospitalMedicalSchool,UK
Diseaee and cerdiac specific autoantibodies are found by immunofluores-
cenoa in 25% of patienta with idiopathic dilated cardiomyopathy (DCM), but
the technique does not define antigenic specificities. Previous studies by
Western blotting identifying antigens used denaturing techniques with loss of
3 dimensional atruoture. We employed a nondenaturing isoelectric focusing
technique to separate cardiac proteins.
Sera was obtained from 4S consecutive pte with DCM (WHO criteria),
44 pta with heart failure secmndaryto iachemic heart disease (IHD), and
49 normals. Human atrial tissue was separated by isoelectric point into 20
fractions which were neutralised and then usadas antigens in ELlSA (dilution
1/300). Responses specific to DCM were identified in fractions 6, 14, 18 of
pH 4.4,6.1,7.7, respectively.
Autoentibodies in DCM were associated with greater EF,V02 max. slL-
2R, [Na], and CK isoforrns and tendad to be associated with good prognosis.
Fraction DCM n (“L+ IHD n (%) normal n (%)
6 9 (19%) p <0.01 1 (24A) o
6 (12%) D = 0.05 1 (2%)14 1 [2”/.)
1s 7 i15%j ” 1 i20/.j 4 iwoj
Cardiac antibodies detected by ELISA using non denatured protein frec-
tiOnSare Soecificto DCM and seem to be associated with early disease and
results and further support an immune pathogenesis in some DCM patients.
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FI lmmunoadaorPtio.aaa~e~~haraPauti. Prin.iP,.
in Dilatad Cardiomyopathy
S.B. Felix, W.V. DMfel, G. Wallukat, G. Baumann. Med.MinikL Charit6and
MaxDa/btickCentra,Berlin,Germany
Previous studies have shown that the sera of many patients with dilated
cardiomyopathy (DCM) contain antibodies to different cardiac antigens. Ra-
cantly,circulating antibodies tothe~l-adrenergic receptor had been detected
in patienta with DCM. These antibodies are extractable by immunoadsorp-
tion (1A).The present study was performed to answer the question whether
removement of circulating antibodies improves cardiac function of patients
with DCM.
Immunoglobulins were eliminated in 9 patients with severe DCM (mean
age 43.5; LVEF < 259’o).1Awas performed on 5 consecutive days using an
immunoadsorber for immunoglobulin. All patients were on stable medication,
including ACE inhibitors, digitalis and diuretics. All patients also received
~-blockers. Hemodynamic parameters were monitored using a Swan-Ganz
therrnodilution catheter. Prior to 1Ahemodynamics were on stable baseline.
Analysis of @l-reoeptorantibodies wasusad asamarkerforautoimmunologic
reactions occurring in DCM.
1Acaused a decrease of anti ,81-receptorantibodies from 6.4+ 1.3to 1.0
+ 0.5 relative units. In addition, a decrease was detected in immunoglobulin
(Ig) G (from 11.5 to 1.5 @l) and lgM (from 1.9 to 0.4 @l). In all patients 1A
was well tolerated and no major complications occurred. During 1A,cardiac
index increaaad from 2.0 + 0.4 to 2.9 + 0.6 l/min/rr#, p < 0.05. Mean
arterial pressure decreased from 76* 10 to 65 + 11 mmHg, p <0.05, mean
pulmonary arterial pressure from 27 + 8 to 22 + 6 mmHg, p c 0.05, left
ventricular enddiastolic filling pressure from 17 + 7 to 13 + 5 mmHg, p <
0.05, and systemic vascular resistance from 1465 + 332 to 949 + 351 dyn x
s x cm–5, p c 0.05.
Cone/usion:lnconjunction with conventional medical treatment, immunoad-
sorption may be an additional therapeutic principle for acute hemodynamic
stabilization of patients with severe dilated cardiomyopathy.
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1765-6]EndomYocardia,~ioPaY~rovanc rdiac
Amyloidoaia in tha Abaence of Echocardiographic
Featurea of Infiltrative Cardiomyopathy
M. Grogan, M.A. Gertz, P.A.Pellikka, R.A. Kyle, A.J. Tajik. Mayo Clinic,
RochestefiMN,USA
Typical echocardiographic findings of cardiac involvement in prima~ systolic
amyloidosis (AL) have been well described including increased left ven-
tricular wall thicknesses (LVWT), granular sparkling, systolic and diastolic
dysfunction. Whether echocardiogrephic abnormalities are present in all pts
with AL heart disease is unknown. The purpose of this study wea to deter-
mine the frequency of false negative echocardiographic studies in pta with
endomyocardial biopsy (EMB) proven cardiac AL. A retrospective review of
all pta with primary systemic AL aeen at the Mayo Clinic (1978 to 1995)
was performed. Pta who had a positive EMB for AL infiltration and who
had undergone eohocerdiographic examination were included. Results:Of
1386 AL pts, 124 had a pcsitive EMB. Five of these pts (4%) were identified
in whom LVWT were normal (mean septal thickness 11 + 1 mm) and the
echocardiographic interpretation was not consistent with cardiac AL. All had
extensive cardiac interstitial and perivascular AL infiltration demonatratad by
EMB. Mean ejection fraction wae 57 + 14Y0.Mean mitral deceleration time
was 16S+30 msec. Only one pt was felt to have abnormal diastolic function
on prospective evaluation, although on retrospective review, all were inter-
preted as abnormal. All pts were symptomatic, four presented with severe
dyspnea on exertion and one with overt congestive heart failure.
Cone/uaion:Extensive cardiac AL infiltration may occur in the absence
of increased LVWT or other echocardiographic findings of infiltrative car-
diomyopathy. Recognition of abnormal diastolic function ancflor abnormal
serumdurine eleotrophoresis may suggest the diagnosis in pta presenting
with dyspnea or unexplained cardiomyopathy.
